BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 2814071)

  • 1. Estimation of prevalence on the basis of screening tests.
    Lew RA; Levy PS
    Stat Med; 1989 Oct; 8(10):1225-30. PubMed ID: 2814071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence estimation when disease status is verified only among test positives: Applications in HIV screening programs.
    G Thomas E; B Peskoe S; Spiegelman D
    Stat Med; 2018 Mar; 37(7):1101-1114. PubMed ID: 29230839
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bayesian and mixed Bayesian/likelihood criteria for sample size determination.
    Joseph L; du Berger R; Bélisle P
    Stat Med; 1997 Apr; 16(7):769-81. PubMed ID: 9131764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dual screening.
    Johnson WO; Pearson LM
    Biometrics; 1999 Sep; 55(3):867-73. PubMed ID: 11315019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bayesian estimation of intervention effect with pre- and post-misclassified binomial data.
    Stamey JD; Seaman JW; Young DM
    J Biopharm Stat; 2007; 17(1):93-108. PubMed ID: 17219757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bayesian inference on prevalence using a missing-data approach with simulation-based techniques: applications to HIV screening.
    Mendoza-Blanco JR; Tu XM; Iyengar S
    Stat Med; 1996 Oct; 15(20):2161-76. PubMed ID: 8910961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estimation of Probability Distribution and Its Application in Bayesian Classification and Maximum Likelihood Regression.
    Dai H; Wang W; Xu Q; Xiong Y; Wei DQ
    Interdiscip Sci; 2019 Sep; 11(3):559-574. PubMed ID: 31317443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bayes theorem: Fully informed rational estimates of diagnostic probabilities.
    J Am Dent Assoc; 2010 Jun; 141(6):658-9. PubMed ID: 20516096
    [No Abstract]   [Full Text] [Related]  

  • 9. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
    Liu C; Xie J; Zhang Y
    Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bayesian estimates of linkage disequilibrium.
    Sebastiani P; Abad-Grau MM
    BMC Genet; 2007 Jun; 8():36. PubMed ID: 17592642
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bayesian approach to decompression sickness model parameter estimation.
    Howle LE; Weber PW; Nichols JM
    Comput Biol Med; 2017 Mar; 82():3-11. PubMed ID: 28119191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the diagnosis of bipolar disorder: predictive value of screening tests.
    Phelps JR; Ghaemi SN
    J Affect Disord; 2006 Jun; 92(2-3):141-8. PubMed ID: 16529822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening without a "gold standard": the Hui-Walter paradigm revisited.
    Johnson WO; Gastwirth JL; Pearson LM
    Am J Epidemiol; 2001 May; 153(9):921-4. PubMed ID: 11323324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review and comparison of Bayesian and likelihood-based inferences in beta regression and zero-or-one-inflated beta regression.
    Liu F; Eugenio EC
    Stat Methods Med Res; 2018 Apr; 27(4):1024-1044. PubMed ID: 27230127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Univariate and bivariate likelihood-based meta-analysis methods performed comparably when marginal sensitivity and specificity were the targets of inference.
    Dahabreh IJ; Trikalinos TA; Lau J; Schmid CH
    J Clin Epidemiol; 2017 Mar; 83():8-17. PubMed ID: 28063915
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequentist and Bayesian approaches to prevalence estimation using examples from Johne's disease.
    McV Messam LL; Branscum AJ; Collins MT; Gardner IA
    Anim Health Res Rev; 2008 Jun; 9(1):1-23. PubMed ID: 18346298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classical and Bayesian inference in neuroimaging: applications.
    Friston KJ; Glaser DE; Henson RN; Kiebel S; Phillips C; Ashburner J
    Neuroimage; 2002 Jun; 16(2):484-512. PubMed ID: 12030833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Bayesian model to estimate the cutoff and the clinical utility of a biomarker assay.
    Vradi E; Jaki T; Vonk R; Brannath W
    Stat Methods Med Res; 2019 Aug; 28(8):2538-2556. PubMed ID: 29966502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marginal likelihood estimation of negative binomial parameters with applications to RNA-seq data.
    León-Novelo L; Fuentes C; Emerson S
    Biostatistics; 2017 Oct; 18(4):637-650. PubMed ID: 28369228
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MLE and Bayesian inference of age-dependent sensitivity and transition probability in periodic screening.
    Wu D; Rosner GL; Broemeling L
    Biometrics; 2005 Dec; 61(4):1056-63. PubMed ID: 16401279
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.